Clinical & Translational Immunology
An open access, online-only journal, covering basic, translational and clinical studies in all aspects of human immunology
2021 Impact Factor: 6.515
2021 Scopus CiteScore: 6.4
CLINICAL & TRANSLATIONAL IMMUNOLOGY COVERS:
- Cancer biology
- Cardiovascular research
- Gene therapy
- Immunology
- Vaccine development
- Disease pathogenesis and therapy at the earliest phases of investigation
FEATURES OF CLINICAL & TRANSLATIONAL IMMUNOLOGY INCLUDE:
- Rapid Review Process
- Average Time to First Decision of < 30 days
- Open Access – anyone can download and read your paper
- 2018 Impact Factor 7.271
- 2019 Impact Factor 6.464
- Now listed on PubMed Central
- Full peer review
- Original Articles, Reviews, Case Reports, Letters to Editors, Theoretical Articles, Short Communications
- Special Features
- Supported by a distinguished and international Editorial Board
- Member of COPE for responsible publication ethics
- Publishes only the most important advances in biomedical research
- Eligibility for the CTI Social Impact Award
ADDITIONAL BENEFITS FOR ASI MEMBERS
- Receive a 20% discount off the cost of publishing in CTI*
- Be in the running for the award of ‘CTI Publication of the Year’, which also includes a speakers slot at the ASI annual meeting*** BRAND NEW IN 2018!
*Eligible only to current financial ASI members. To receive the member-only code, please contact us.
***Awarded to the best publication from a current financial ASI member who is first author.
CTI website Submit a manuscript Download the CTI flyer
